By stimulating receptors in the brain, GLP-1s help you feel full sooner, reduce hunger, and slow down digestion, leading to a significant reduction in calorie intake
Semaglutide activates GLP-1 receptors in the brain's temperature-regulating center, which can increase perspiration as your body adjusts to the medication
Enzyme activity, particularly from proteases present in biological samples like plasma or cell lysates, is a primary driver of peptide degradation
Discontinuation rates due to GI intolerance were 3-7% across doses, comparable to tirzepatide
Unlike SGLT2 inhibitors, semaglutide does not have diuretic properties that directly increase urine output
Varicocele and scrotal hyperthermia have also been shown to associate with ferroptosis [107, 123, 124]